Masoumeh Tavakoli-Yaraki

17PUBLICATIONS
1CO-AUTHORS
Medical biochemistry - carbohydratesPredictive and prognostic markersChemotherapyCancer diagnosisCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 16, 2026
Adaptation to glucose restriction and β-hydroxybutyrate supplementation is associated with metabolic flexibility in lung cancer cells.

|Jul 02, 2025
SOX9 expression in circulation and tumor site of lung cancer; diagnostic potential and demographic associations.

Ali Karami, Banafsheh Safizadeh, Pegah Babaheidarian

|Jan 09, 2025
Exploring the potential of gemcitabine-metal-organic frameworks in combating pancreatic cancer under ketogenic conditions.

Samira Nekoufar, Marjan Ghorbani, Sahar Safaei

|Nov 15, 2024
Therapeutic potential of β-hydroxybutyrate in the management of pancreatic neoplasms: exploring novel diagnostic and treatment strategies.

Mohammad Amin Vaezi, Samira Nekoufar, Ali Karami Robati

|Oct 03, 2024
Assessment of the circulating levels of immune system checkpoint selected biomarkers in patients with lung cancer.

Banafsheh Safizadeh, Maryam Sadeh, Ali Karami Robati

|Apr 24, 2024
Beta hydroxybutyrate induces lung cancer cell death, mitochondrial impairment and oxidative stress in a long term glucose-restricted condition.

Farzad Izak Shirian, Milad Karimi, Maryam Alipour

Pageof 3

Frequent Collaborators

1 joint publications

Behzad Baradaran